Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
21/07/2009 | 16:54 | Dow Jones News | UPDATE: Drug Makers' Profits Beat Views Despite Lower Sales | BIT:ABT | Abbott Laboratories |
21/07/2009 | 15:47 | Dow Jones News | Merck, Schering 2Q Profits Beat Views Despite Lower Sales | BIT:ABT | Abbott Laboratories |
21/07/2009 | 15:30 | PR Newswire (US) | Labs Are Vital(TM) Announces Winners of 2009 National Video Contest to Highlight Careers in Lab Sciences | BIT:ABT | |
15/07/2009 | 23:20 | Dow Jones News | Generic Drug Co Recalls Acetaminophen To Avoid Dose Confusion | BIT:ABT | Abbott Laboratories |
15/07/2009 | 17:47 | Dow Jones News | 2nd UPDATE: Abbott Not Interested In Solvay's Tricor Operations | BIT:ABT | Abbott Laboratories |
15/07/2009 | 17:03 | Dow Jones News | UPDATE:Abbott Laboratories Not Bidding For Solvay Tricor Operations | BIT:ABT | Abbott Laboratories |
15/07/2009 | 16:50 | Dow Jones News | UPDATE: Abbott Labs 2Q Profit Down 2.6%, Gives Cautious View | BIT:ABT | Abbott Laboratories |
15/07/2009 | 16:40 | Dow Jones News | US EARNINGS WRAP: Abbott Profit Down, Gannett Back In Black | BIT:ABT | Abbott Laboratories |
15/07/2009 | 16:28 | Dow Jones News | Abbott Laboratories Not Bidding For Solvay's Tricor Operations | BIT:ABT | Abbott Laboratories |
15/07/2009 | 15:05 | Dow Jones News | Abbott Labs 2Q Profit Down 2.6%, Gives Cautious View | BIT:ABT | Abbott Laboratories |
14/07/2009 | 18:00 | Dow Jones News | 3rd UPDATE: J&J's 2Q Profit Down 3.6% On Forex, Generics | BIT:ABT | Abbott Laboratories |
14/07/2009 | 16:33 | Dow Jones News | 2nd UPDATE: J&J 2Q Profit Down 3.6% On Forex, Generics | BIT:ABT | Abbott Laboratories |
13/07/2009 | 20:07 | Dow Jones News | Abbott, GSK To Develop Molecular Diagnostic Test | BIT:ABT | Abbott Laboratories |
10/07/2009 | 20:53 | Dow Jones News | US EQUITIES WEEK AHEAD: Banks, Tech Report; Sotomayor Hearing | BIT:ABT | Abbott Laboratories |
08/07/2009 | 23:58 | Dow Jones News | 2nd UPDATE: Trial Of Cholesterol Drugs Terminated | BIT:ABT | Abbott Laboratories |
08/07/2009 | 23:33 | Dow Jones News | UPDATE: Trial Of Cholesterol Drugs Terminated | BIT:ABT | Abbott Laboratories |
08/07/2009 | 22:53 | Dow Jones News | Trial Of Abbott, Merck/Schering Cholesterol Drugs Terminated | BIT:ABT | Abbott Laboratories |
08/07/2009 | 05:29 | Dow Jones News | UPDATE: Kennedy Breaks With White House Over Biologics | BIT:ABT | Abbott Laboratories |
08/07/2009 | 04:48 | Dow Jones News | Kennedy Breaks With White House Over Biologics | BIT:ABT | Abbott Laboratories |
07/07/2009 | 22:55 | Dow Jones News | UPDATE: Abbott Labs Names New Head Of Pharmaceutical Unit | BIT:ABT | Abbott Laboratories |
07/07/2009 | 18:09 | Dow Jones News | Abbott Labs Names New Head Of Pharmaceutical Unit | BIT:ABT | Abbott Laboratories |
01/07/2009 | 16:55 | Dow Jones News | Acura, King Could Benefit From FDA Panel Votes On Pain Drugs | BIT:ABT | Abbott Laboratories |
01/07/2009 | 01:00 | Dow Jones News | 3rd UPDATE: FDA Panel For Eliminating Some Acetaminophen Products | BIT:ABT | Abbott Laboratories |
30/06/2009 | 22:20 | Dow Jones News | 2nd UPDATE: FDA Panel For Eliminating Some Acetaminophen Products | BIT:ABT | Abbott Laboratories |
30/06/2009 | 17:41 | Dow Jones News | Report: Cost Should Play Role In Comparing Medical Treatments | BIT:ABT | Abbott Laboratories |
23/06/2009 | 14:00 | PR Newswire (US) | Abbott Receives CE Mark for Company's Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Advancing Leadership Position | BIT:ABT | |
19/06/2009 | 16:48 | Dow Jones News | FDA Staff Recommends Updated Warning For Asmanex | BIT:ABT | Abbott Laboratories |
12/06/2009 | 16:50 | PR Newswire (US) | Abbott Declares 342nd Consecutive Quarterly Dividend | BIT:ABT | |
10/06/2009 | 18:11 | Dow Jones News | Abbott CEO: No Interest In Large, 'Mega-Deal' Mergers | BIT:ABT | Abbott Laboratories |
09/06/2009 | 19:09 | Dow Jones News | Successful TriLipix Trials Good News For Solvay - Analysts | BIT:ABT | Abbott Laboratories |